Activation of the IL-6R/Jak/Stat Pathway is Associated with a Poor Outcome in Resected Pancreatic Ductal Adenocarcinoma

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Gastrointestinal Surgery

• Publication date

  2013-02-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11605-013-2168-7PMID 23435739
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Relationship Between Tumor Inflammatory Cell Infiltrate and Outcome in Patients with Pancreatic Ductal Adenocarcinoma

  2012cited by this paper
• Obesity and pancreatic cancer: Overview of epidemiologic evidence and biologic mechanisms

  2012cited by this paper
• JAKs go nuclear: Emerging role of nuclear JAK1 and JAK2 in gene expression and cell growth

  2011cited by this paper
• Activation of the PIK3CA/AKT pathway suppresses senescence induced by an activated RAS oncogene to promote tumorigenesis.

  2011cited by this paper
• A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study.

  2011cited by this paper
• Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice.

  2011cited by this paper
• A Prospective Comparison of the Prognostic Value of Tumor- and Patient-Related Factors in Patients Undergoing Potentially Curative Surgery for Pancreatic Ductal Adenocarcinoma

  2011cited by this paper
• Combined Blockade of Src Kinase and Epidermal Growth Factor Receptor with Gemcitabine Overcomes STAT3-Mediated Resistance of Inhibition of Pancreatic Tumor Growth

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• STAT3 Expression, Molecular Features, Inflammation Patterns, and Prognosis in a Database of 724 Colorectal Cancers

  2011cited by this paper
• STAT3 Knockdown Reduces Pancreatic Cancer Cell Invasiveness and Matrix Metalloproteinase-7 Expression in Nude Mice

  2011cited by this paper
• Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer.

  2011cited by this paper
• STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis.

  2011cited by this paper
• The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment.

  2011cited by this paper
• Taming the dragon: genomic biomarkers to individualize the treatment of cancer

  2011cited by this paper
• Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression.

  2011cited by this paper
• Dual roles for immunity in gastrointestinal cancers.

  2010cited by this paper
• Positive Mobilization Margins Alone Do Not Influence Survival Following Pancreatico-Duodenectomy for Pancreatic Ductal Adenocarcinoma

  2010cited by this paper
• Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells.

  2010cited by this paper
• Energy balance, host-related factors, and cancer progression.

  2010cited by this paper
• Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer

  2010cited by this paper
• The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors.

  2009cited by this paper
• Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe

  2009cited by this paper
• Clinical Significance of Interleukin-6 (Il-6) Gene Polymorphism and Il-6 Serum Level in Pancreatic Adenocarcinoma and Chronic Pancreatitis

  2009cited by this paper
• Inflammation and cancer: IL-6 and STAT3 complete the link.

  2009cited by this paper
• Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer

  2009cited by this paper
• Targeting the hypoxia-inducible factor (HIF) pathway in cancer

  2009cited by this paper
• STATs in cancer inflammation and immunity: a leading role for STAT3

  2009cited by this paper
• Toxicogenomic analysis of mainstream tobacco smoke-exposed mice reveals repression of plasminogen activator inhibitor-1 gene in heart.

  2009cited by this paper
• Expression of nuclear notch3 in pancreatic adenocarcinomas is associated with adverse clinical features, and correlates with the expression of STAT3 and phosphorylated Akt

  2008cited by this paper
• Insulin resistance, serum adiponectin, and proinflammatory markers in young subjects with the metabolic syndrome.

  2008cited by this paper
• Cancer Statistics, 2008

  2008cited by this paper
• Toxicogenomic Analysis of Mainstream Tobacco Smoke-Exposed Mice Reveals Repression of Plasminogen Activator Inhibitor-1 Gene in Heart

  2008cited by this paper
• Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer

  2007cited by this paper
• Targeting Heat Shock Protein 90 in Pancreatic Cancer Impairs Insulin-like Growth Factor-I Receptor Signaling, Disrupts an Interleukin-6/Signal-Transducer and Activator of Transcription 3/Hypoxia-Inducible Factor-1α Autocrine Loop, and Reduces Orthotopic Tumor Growth

  2007cited by this paper
• Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice.

  2007cited by this paper
• Redefining the R1 resection in pancreatic cancer

  2006cited by this paper
• Observer variation in immunohistochemical analysis of protein expression, time for a change?

  2006cited by this paper
• Persistent expression of PDX-1 in the pancreas causes acinar-to-ductal metaplasia through Stat3 activation.

  2006cited by this paper
• Evaluation of an Inflammation-Based Prognostic Score in Patients with Inoperable Pancreatic Cancer

  2006cited by this paper
• Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion

  2006cited by this paper
• Role of Mononuclear Cells and Inflammatory Cytokines in Pancreatic Cancer-Related Cachexia

  2005cited by this paper
• Cytokines in pancreatic carcinoma

  2004cited by this paper
• Inflammatory Mechanisms Contributing to Pancreatic Cancer Development

  2004cited by this paper
• Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer.

  2003cited by this paper
• Modulation of signal transducer and activator of transcription 3 activities by p53 tumor suppressor in breast cancer cells.

  2002cited by this paper
• Influence of Resection Margins on Survival for Patients With Pancreatic Cancer Treated by Adjuvant Chemoradiation and/or Chemotherapy in the ESPAC-1 Randomized Controlled Trial

  2001cited by this paper
• Predictors of pancreatic cancer mortality among a large cohort of United States adults

  2000cited by this paper
• Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database.

  1999cited by this paper
• Transcriptional responses to polypeptide ligands: the JAK-STAT pathway.

  1995cited by this paper
• Pancreatitis and the risk of pancreatic cancer

  1993cited by this paper
• Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group.

  1993cited by this paper
• Differential regulation of interleukin-6 receptor and gp130 gene expression in rat hepatocytes.

  1992cited by this paper
• Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors.

  1986cited by this paper

• CRISPR screen of human pancreatic cancer xenografts identifies a KLF5 proliferation vulnerability through epigenetic modifiers NCAPD2 and MTHFD1.

  2026cites this paper
• Calothrixin B by docking JAK2 is a potential therapeutic inhibitor for pancreatic ductal adenocarcinoma.

  2025cites this paper
• Long non-coding RNAs (lncRNAs) in cancer development: new insight from STAT3 signaling pathway to immune evasion

  2025cites this paper
• The Dynamic Interplay between Melanoma Cells and CAFs: Implications Drug Resistance and Immune Evasion and Possible Therapeutics.

  2025cites this paper
• The IL-6/JAK/STAT3 Axis in Cholangiocarcinoma and Primary Sclerosing Cholangitis: Unlocking Therapeutic Strategies Through Patient-Derived Organoids

  2025cites this paper
• Pathophysiology-Driven Approaches for Overcoming Nanomedicine Resistance in Pancreatic Cancer.

  2024cites this paper
• JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors

  2024cites this paper
• Network pharmacology study to explore the multiple molecular mechanism of SH003 in the treatment of non-small cell lung cancer

  2024cites this paper
• Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial

  2023cites this paper
• Polarization of Cancer-Associated Macrophages Maneuver Neoplastic Attributes of Pancreatic Ductal Adenocarcinoma

  2023influential citation
• Novel Histopathological Biomarkers in Prostate Cancer: Implications and Perspectives

  2023cites this paper
• Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study

  2023cites this paper
• Orchestration of mesenchymal plasticity and immune evasiveness via rewiring of the metabolic program in pancreatic ductal adenocarcinoma

  2022cites this paper
• Gp130 is expressed in pancreatic cancer and can be targeted by the small inhibitor molecule SC144

  2022cites this paper
• Exploration of the System-Level Mechanisms of the Herbal Drug FDY003 for Pancreatic Cancer Treatment: A Network Pharmacological Investigation

  2022cites this paper
• Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression

  2022cites this paper
• Gene Expression Profiling and Protein Analysis Reveal Suppression of the C-Myc Oncogene and Inhibition JAK/STAT and PI3K/AKT/mTOR Signaling by Thymoquinone in Acute Myeloid Leukemia Cells

  2022cites this paper
• Central Roles of STAT3-Mediated Signals in Onset and Development of Cancers: Tumorigenesis and Immunosurveillance

  2022cites this paper
• Aberrant transcription factors in the cancers of the pancreas.

  2022cites this paper
• Emerging kinase inhibitors for the treatment of pancreatic ductal adenocarcinoma

  2022cites this paper
• Discovery of a Highly Potent and Orally Bioavailable STAT3 Dual Phosphorylation Inhibitor for Pancreatic Cancer Treatment.

  2022cites this paper
• The Gain-of-Function p53 R248W Mutant Promotes Migration by STAT3 Deregulation in Human Pancreatic Cancer Cells

  2021cites this paper
• Myeloid‐derived suppressor cells: Bridging the gap between inflammation and pancreatic adenocarcinoma

  2021cites this paper
• The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies

  2021cites this paper
• miR-20b and miR-125a promote tumorigenesis in radioresistant esophageal carcinoma cells

  2021cites this paper
• GATA4 Regulates Inflammation-Driven Pancreatic Ductal Adenocarcinoma Progression

  2021cites this paper
• Therapeutic targeting of STAT3 pathways in pancreatic adenocarcinoma: A systematic review of clinical and preclinical literature

  2021cites this paper
• Ketogenic Diets in Pancreatic Cancer and Associated Cachexia: Cellular Mechanisms and Clinical Perspectives

  2021cites this paper
• Ganoderma lucidum put forth anti-tumor activity against PC-3 prostate cancer cells via inhibition of Jak-1/STAT-3 activity

  2020cites this paper
• Emerging roles for the IL-6 family of cytokines in pancreatic cancer

  2020cites this paper
• LDL cholesterol promotes the proliferation of prostate and pancreatic cancer cells by activating the STAT3 pathway

  2020cites this paper
• Influence of Indoleamine-2,3-Dioxygenase and Its Metabolite Kynurenine on γδ T Cell Cytotoxicity against Ductal Pancreatic Adenocarcinoma Cells

  2020cites this paper
• Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling

  2020cites this paper
• Strategies of Targeting Pathological Stroma for Enhanced Antitumor Therapies.

  2019cites this paper
• [Nutritional Support for Patients with Pancreatic Cancer].

  2019cites this paper
• Sesame Inhibits Cell Proliferation and Induces Apoptosis through Inhibition of STAT-3 Translocation in Thyroid Cancer Cell Lines (FTC-133)

  2019cites this paper
• FAK-regulated IL6 reprograms the tumour associated macrophage phenotype and promotes pancreatic tumour growth

  2019cites this paper
• Computational STAT3 activity inference reveals its roles in the pancreatic tumor microenvironment

  2019cites this paper
• Blocking IL-6/GP130 Signaling Inhibits Cell Viability/Proliferation, Glycolysis, and Colony Forming Activity in Human Pancreatic Cancer Cells.

  2019cites this paper
• Sequential Targeting TGF-β Signaling and KRAS Mutation Increases Therapeutic Efficacy in Pancreatic Cancer.

  2019cites this paper
• Obesity-Induced Adipose Tissue Inflammation as a Strong Promotional Factor for Pancreatic Ductal Adenocarcinoma

  2019cites this paper
• p66Shc promotes HCC progression in the tumor microenvironment via STAT3 signaling.

  2019cites this paper
• Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC)

  2018cites this paper
• OSMR gene effect on the pathogenesis of chronic autoimmune Urticaria via the JAK/STAT3 pathway

  2018cites this paper
• Clinicopathological significance and prognostic role of p-STAT3 in patients with hepatocellular carcinoma

  2018cites this paper
• Molecularly Targeted Therapies in Pancreatic Cancer

  2018cites this paper
• Expression of phosphorylated estrogen receptor beta is an independent negative prognostic factor for pancreatic ductal adenocarcinoma

  2018cites this paper
• Possible Molecular Markers for the Diagnosis of Pancreatic Ductal Adenocarcinoma

  2018cites this paper
• Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma

  2018cites this paper
• Pancreatic Cancer-Induced Cachexia and Relevant Mouse Models.

  2018cites this paper
• Cancer-Associated Fibroblasts in Pancreatic Cancer: Should They Be Deleted or Reeducated?

  2018cites this paper
• STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial.

  2018cites this paper
• The role of the interleukin (IL)-6/IL-6 receptor axis in cancer.

  2018cites this paper
• IL-6 roles - Molecular pathway and clinical implication in pancreatic cancer - A systemic review.

  2017cites this paper
• Serum interleukin-6 is associated with pancreatic ductal adenocarcinoma progression pattern

  2017cites this paper
• OSU-A9 inhibits pancreatic cancer cell lines by modulating p38-JAK-STAT3 signaling

  2017cites this paper
• Aus der Klinik für Allgemein-, Viszeral- und Gefäßchirurgie der Medizinischen Fakultät Charité – Universitätsmedizin Berlin DISSERTATION Expression of phosphorylated estrogen receptor beta is an independent negative prognostic factor in pancreatic ductal adenocarcinoma

  2017cites this paper
• SF3B4 is decreased in pancreatic cancer and inhibits the growth and migration of cancer cells

  2017cites this paper
• Potent EMT and CSC Phenotypes Are Induced By Oncostatin-M in Pancreatic Cancer

  2017cites this paper
• EGFR-induced phosphorylation of type Iγ phosphatidylinositol phosphate kinase promotes pancreatic cancer progression

  2017cites this paper
• Identifying the Role of Janus Kinase 1 in Mammary Gland Development and Breast Cancer

  2017cites this paper
• Role of STAT3 in Pancreatic Cancer: A target for therapy

  2017cites this paper
• ERK1/2, JNK and STAT3 activation and correlation with tumor differentiation in oral SCC.

  2017cites this paper
• Clinicopathological Implications of Wingless/int1 (WNT) Signaling Pathway in Pancreatic Ductal Adenocarcinoma.

  2016cites this paper
• Targeting inflammation in pancreatic cancer: Clinical translation.

  2016cites this paper
• Recent Advances and Prospects for Multimodality Therapy in Pancreatic Cancer.

  2016cites this paper
• Management of Metastatic Pancreatic Adenocarcinoma.

  2016cites this paper
• Prognostic role of STAT3 in solid tumors: a systematic review and meta-analysis

  2016cites this paper
• Signal Transduction and Activator of Transcription-3 (STAT3) in Patients with Colorectal Cancer: Associations with the Phenotypic Features of the Tumor and Host

  2016cites this paper
• Cytokine Regulation of Metastasis and Tumorigenicity.

  2016cites this paper
• Diosmin induce apoptosis through modulation of STAT-3 signaling in 7,12 dimethylbenz(a)anthracene induced harmster buccal pouch carcinogenesis.

  2016cites this paper
• Effect of UVB irradiation on JAK-STAT pathway and IL-6, L-8 in Human umbilical vein endothelial cells

  2016cites this paper
• Single agent BMS-911543 Jak2 inhibitor has distinct inhibitory effects on STAT5 signaling in genetically engineered mice with pancreatic cancer

  2015cites this paper
• Inflammatory cytokines regulate the expression of glycosyltransferases involved in the biosynthesis of tumor-associated sialylated glycans in pancreatic cancer cell lines.

  2015cites this paper
• Prognosis Relevance of Serum Cytokines in Pancreatic Cancer

  2015cites this paper
• MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.

  2015cites this paper
• Review of STAT3 (Signal Transducers and Activators of Transcription) in head and neck cancer.

  2015cites this paper
• The pseudokinase SgK223 promotes invasion of pancreatic ductal epithelial cells through JAK1/Stat3 signaling

  2015cites this paper
• Novel Therapeutics for Pancreatic Adenocarcinoma.

  2015cites this paper
• Prognostic Role of Phospho-STAT3 in Patients with Cancers of the Digestive System: A Systematic Review and Meta-Analysis

  2015influential citation
• A New Scalpel for the Treatment of Pancreatic Cancer: Targeting Stromal-Derived STAT3 Signaling.

  2015cites this paper
• RE: nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial.

  2015cites this paper
• nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: long-term survival from a phase III trial.

  2015cites this paper
• Biomarkers for pancreatic cancer : identification, validation and clinical application

  2015cites this paper
• Effect of oridonin-mediated hallmark changes on inflammatory pathways in human pancreatic cancer (BxPC-3) cells.

  2014cites this paper
• Regulation and function of silayltransferases in pancreatic cancer

  2014cites this paper
• Prognostic significance of WNTsignaling in pancreatic ductal adenocarcinoma

  2014cites this paper
• IL-6 and related cytokines as the critical lynchpins between inflammation and cancer.

  2014cites this paper
• Phospho-flow detection of constitutive and cytokine-induced pSTAT3/5, pAKT and pERK expression highlights novel prognostic biomarkers for patients with multiple myeloma

  2014cites this paper
• Prognostic significance of WNT signaling in pancreatic ductal adenocarcinoma

  2014cites this paper
• Curcumin suppresses invasiveness and vasculogenic mimicry of squamous cell carcinoma of the larynx through the inhibition of JAK-2/STAT-3 signaling pathway.

  2014cites this paper
• Astaxanthin Inhibits JAK/STAT-3 Signaling to Abrogate Cell Proliferation, Invasion and Angiogenesis in a Hamster Model of Oral Cancer

  2014cites this paper
• Paracrine SDF-1α signaling mediates the effects of PSCs on GEM chemoresistance through an IL-6 autocrine loop in pancreatic cancer cells

  2014cites this paper
• Expression of KOC, S100P, mesothelin and MUC1 in pancreatico-biliary adenocarcinomas: development and utility of a potential diagnostic immunohistochemistry panel

  2014cites this paper
• STAT3 down regulates LC3 to inhibit autophagy and pancreatic cancer cell growth

  2014cites this paper